Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002329947 | SCV002627775 | uncertain significance | Cardiovascular phenotype | 2019-05-02 | criteria provided, single submitter | clinical testing | The p.G14204E variant (also known as c.42611G>A), located in coding exon 153 of the TTN gene, results from a G to A substitution at nucleotide position 42611. The glycine at codon 14204 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear |
Revvity Omics, |
RCV003138185 | SCV003827356 | uncertain significance | not provided | 2019-05-20 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003487027 | SCV004240085 | likely benign | Cardiomyopathy | 2022-11-14 | criteria provided, single submitter | clinical testing |